DK4061344T3 - 6-hydroxycannabidiol til anvendelse som lægemiddel - Google Patents

6-hydroxycannabidiol til anvendelse som lægemiddel Download PDF

Info

Publication number
DK4061344T3
DK4061344T3 DK20815902.0T DK20815902T DK4061344T3 DK 4061344 T3 DK4061344 T3 DK 4061344T3 DK 20815902 T DK20815902 T DK 20815902T DK 4061344 T3 DK4061344 T3 DK 4061344T3
Authority
DK
Denmark
Prior art keywords
hydroxycannabidiol
medicinal use
medicinal
Prior art date
Application number
DK20815902.0T
Other languages
English (en)
Inventor
Geoffrey Guy
Volker Knappertz
Benjamin Whalley
Marie Woolley-Roberts
Original Assignee
Gw Res Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gw Res Limited filed Critical Gw Res Limited
Application granted granted Critical
Publication of DK4061344T3 publication Critical patent/DK4061344T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK20815902.0T 2019-11-21 2020-11-18 6-hydroxycannabidiol til anvendelse som lægemiddel DK4061344T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1916974.7A GB201916974D0 (en) 2019-11-21 2019-11-21 Cannabidol-type cannabinoid compound
PCT/GB2020/052942 WO2021099781A1 (en) 2019-11-21 2020-11-18 Cannabidiol-type cannabinoid compound

Publications (1)

Publication Number Publication Date
DK4061344T3 true DK4061344T3 (da) 2024-07-08

Family

ID=69137192

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20815902.0T DK4061344T3 (da) 2019-11-21 2020-11-18 6-hydroxycannabidiol til anvendelse som lægemiddel

Country Status (15)

Country Link
US (1) US20230000789A1 (da)
EP (1) EP4061344B1 (da)
JP (1) JP2023503303A (da)
KR (1) KR20220103996A (da)
CN (1) CN114786656A (da)
AU (1) AU2020389360A1 (da)
BR (1) BR112022009539A2 (da)
CA (1) CA3158182A1 (da)
DK (1) DK4061344T3 (da)
FI (1) FI4061344T3 (da)
GB (2) GB201916974D0 (da)
IL (1) IL293033A (da)
MX (1) MX2022005995A (da)
TW (1) TW202132249A (da)
WO (1) WO2021099781A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
CN117396455A (zh) * 2021-05-12 2024-01-12 吉伟研究有限公司 间苯二酚、其制造方法及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002512188A (ja) * 1998-04-21 2002-04-23 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 抗酸化剤及び神経保護剤としてのカンナビノイド類
GB2514054A (en) * 2011-09-29 2014-11-12 Gw Pharma Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US10441617B2 (en) 2013-03-15 2019-10-15 Biotech Institute, Llc Breeding, production, processing and use of medical cannabis
GB2527599A (en) * 2014-06-27 2015-12-30 Gw Pharma Ltd Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
GB2548873B (en) * 2016-03-31 2020-12-02 Gw Res Ltd Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
GB2572125B (en) * 2018-01-03 2021-01-13 Gw Res Ltd Pharmaceutical

Also Published As

Publication number Publication date
GB201916974D0 (en) 2020-01-08
EP4061344A1 (en) 2022-09-28
KR20220103996A (ko) 2022-07-25
CN114786656A (zh) 2022-07-22
GB2591567A9 (en) 2021-12-15
AU2020389360A1 (en) 2022-06-23
BR112022009539A2 (pt) 2022-08-02
CA3158182A1 (en) 2021-05-27
FI4061344T3 (fi) 2024-07-01
MX2022005995A (es) 2022-06-17
WO2021099781A1 (en) 2021-05-27
JP2023503303A (ja) 2023-01-27
GB2591567B (en) 2022-11-16
IL293033A (en) 2022-07-01
GB2591567A (en) 2021-08-04
EP4061344B1 (en) 2024-05-29
US20230000789A1 (en) 2023-01-05
TW202132249A (zh) 2021-09-01
GB202018135D0 (en) 2020-12-30

Similar Documents

Publication Publication Date Title
DK3788040T3 (da) Pyridazinoner som parp7-inhibitorer
DK3697785T3 (da) Imidazo-pyridine forbindelser som pad-inhibitorer
DK3986890T3 (da) Benzisoxazol-sulfonamid-derivater
DK3768674T3 (da) Aminopyrimidinderivater som ctps1-hæmmere
DK3580220T3 (da) Aminotriazolpyridiner som kinasehæmmere
DK3762368T3 (da) Aminopyrazindiolforbindelser som pi3k-y-inhibitorer
DK3634377T3 (da) Farmaceutisk formulering
JP1719667S (ja) ディスペンサー
DE112020001082A5 (de) Löschvorrichtung
CL2019003599S1 (es) Extintor.
DK3348260T3 (da) Farmaceutisk tramadol-sammensætning til oftalmisk anvendelse
DK3870578T3 (da) Terapeutiske forbindelser
DK3704118T3 (da) Aminoimidazopyrazin som kinasehæmmere
DK3762009T3 (da) Toxin-afledte indgivelseskonstrukter til oral indgivelse
DK4061344T3 (da) 6-hydroxycannabidiol til anvendelse som lægemiddel
DK4056557T3 (da) Benzazepinderivater nyttige som medikamenter
DK3601277T3 (da) Farmaceutisk formulering
DE112020004232A5 (de) Unterlegekeil
DK4197391T3 (da) Go-bag til nødsituationer
DK3706710T3 (da) Formuleringer med forlænget frigivelse til intraartikulære anvendelser
DK3908321T3 (da) Farmaceutisk sammensætning
DK3911298T3 (da) Formuleringer
DK3682247T3 (da) Proadrenomedullin som markør for unormale blodpladeniveauer
DK3996688T3 (da) Farmaceutisk præparat
TWI848143B (zh) 灑水頭